Patrick Wang, BHSc
Patrick Wang is a third year medical student at Queen's University. His interest in Ophthalmology started in his first year after observing the excellent care provided in Kingston. He has previous research in pediatric ophthalmology, OCT imaging, and corneal suture techniques. Before medical school, Patrick studied Health Sciences at McMaster University for three years. In his free time, he enjoys cooking, building computers, and photography.
5
New Developments in Retina: 2022 Pharmaceutical Updates
Learn about the emerging treatment options for AMD. Here are the new treatments—such as pipeline therapies, biosimilar alternatives, novel intravitreal agents, and sustained drug delivery systems—that will receive significant attention in the next year.
Study Shows a Decline in Myopia with 2 Hours of Outdoor Time
With myopia becoming a major public health concern in many countries, an emphasis on prevention may prove to best serve patients in the future. Learn the latest on the evolving landscape of myopia prevention.
Ocular Hypertension Treatment Study After 20 Years of Follow-up
The OHTS 20-year follow-up supports the standard of care of using topical ocular hypotensive medications to prevent glaucoma progression in moderate and high-risk patients with ocular hypertension.
The Role of Gene Therapy in Inherited Retinal Diseases
In the past three decades, there have been major advancements in the diagnosis and treatment of inherited retinal diseases, including novel gene therapies. Here's what ophthalmologists should know about these new treatment options.
The Role of Corticosteroids in Diabetic Eye Disease
Diabetic eye disease remains a major cause of vision loss in patients with diabetes. Here, we present the role of corticosteroids in suppressing chronic inflammation and tissue injury specific to DME in the diabetic patient population.